Connect with us

The Dictatorship

The legal resistance to Trump’s barrage of executive actions has begun

Published

on

The legal resistance to Trump’s barrage of executive actions has begun

Welcome back, Deadline: Legal Newsletter readers. After the barrage of executive actions that kicked off Donald Trump’s second term, the legal resistance is taking shape. Lawsuits are being filed and trial courts are weighing inwith judges already dealing the administration a series of losses. But it’s early yet in a process that will likely land at the Supreme Court on several fronts.

“Disingenuous” is how one judge described Trump’s attempt to avoid legal scrutiny of his federal spending freeze. Halting the effort Monday, U.S. District Judge Loren AliKhan wrote that instead of taking “a measured approach to identify purportedly wasteful spending,” the government “cut the fuel supply to a vast, complicated, nationwide machine — seemingly without any consideration for the consequences of that decision.” The Biden appointee’s temporary restraining order in the District of Columbia followed a Rhode Island judge’s order likewise blocking Trump’s bid to “pause” trillions of dollars of congressionally approved funds.

“Untenable” is how another judge described Trump’s argument against birthright citizenship. Reminding the government that it’s an “unequivocal Constitutional right,” U.S. District Judge John Coughenour in Seattle granted a preliminary injunction against the president’s executive order seeking to upend that right. The Reagan appointee’s rebuke echoed a Biden appointee’s ruling affirming the long-standing right, with the latter judge in Maryland writing that Trump’s order “interprets the Citizenship Clause of the Fourteenth Amendment in a manner that the Supreme Court has resoundingly rejected and no court in the country has ever endorsed.”

We’ll see what today’s Supreme Court says about that issue and others poised to reach the justices.

Another brewing Supreme Court test stems from the president removing a National Labor Relations Board member whose congressionally approved term isn’t up until 2028. Trump’s action against Gwynne Wilcox violates a federal law that says presidents can only remove members for cause and with notice and a hearing, none of which Wilcox received, she said in her complaint filed this week. The firing likewise contradicts a 1935 Supreme Court case called Humphrey’s Executor. That precedent was called out for targeting by Project 2025the conservative blueprint that Trump tried to distance himself from during his campaign but has embraced in office.

And that’s just some of the latest legal action prompted by the first days of Trump’s second term. Another development was lawsuits from FBI agents who worked on Jan. 6 cases, who said they feared retaliation from the government they served. In response to the litigation, the Trump administration agreed not to release their names, providing some comfort to agents concerned for their safety because of the actions of the president and his supporters.

Meanwhile, Pam Bondi was confirmed as Trump’s attorney general 54-46. The president’s impeachment lawyer from his first term began by telling Justice Department staff that, contrary to tradition, DOJ lawyers are “his” (i.e. Trump’s) lawyers. As The Washington Post explainedBondi “spent her first day on the job Wednesday redirecting the [DOJ’s] significant law enforcement authority toward addressing [Trump’s] grievances with the agency.”

Elsewhere in Trump’s DOJ, his interim U.S. attorney in the District of Columbia has made his allegiance clear to Trump and his ally Elon Muskwhose actions with his Department of Government Efficiency team have sparked its own emerging legal docket. That temporary top prosecutor, former Jan. 6 defense lawyer And Martinhas been penning dramatic, supportive letters to Musk directly — and, for unexplained reasons, exclusively — on the billionaire’s social media platform. While Martin hasn’t specified who he’s going after on Musk and DOGE’s behalf or in violation of which laws, his public statements do well to capture the new administration’s approach to “law and order.”

And speaking of who gets government protection these daysTrump’s Doj”https://www.supremecourt.gov/DocketPDF/23/23-477/342223/20250207133625781_Letter23-477.pdf” target=”_blank”>just told the Supreme Court that it no longer thinks Tennessee’s ban on gender-affirming care for minors violates the Constitution. Whether it does is at issue in the pending case of United States v. Skrmetti — “United States” leading that case caption because the government during the Biden administration had appealed the issue to the justices. The case was argued last year and is awaiting a decision from the court (likely to come by July). The DOJ didn’t ask the justices to dismiss the appeal, but it wanted the court to know that “the government’s previously stated views no longer represent the United States’ position.” As the brief rundown in this week’s newsletter shows, that understated line is true of much government activity these days.

Have any questions or comments for me? I’d love to hear from you! Please emaildeadlinelegal@nbcuni.comfor a chance to be featured in a future newsletter.

Jordan Rubin

Jordan Rubin is the Deadline: Legal Blog writer. He was a prosecutor for the New York County District Attorney’s Office in Manhattan and is the author of “Bizarro,” a book about the secret war on synthetic drugs. Before he joined BLN, he was a legal reporter for Bloomberg Law.

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

The Dictatorship

Trump’s economy takes a toll on middle-class Americans as his poll numbers on economics fall

Published

on

Trump’s economy takes a toll on middle-class Americans as his poll numbers on economics fall
  • Trump’s winning streak: Law professor breaks down his Supreme Court shadow docket victories

    07:03

  • Now Playing

  • UP NEXT

    How social media can have an influence in attempted assassinations and mass shootings

    11:38

  • What Congress should ask FBI Director Patel about in next week’s Epstein files deposition

    06:23

  • Fmr. Vice President Harris shares internal debate on asking Biden to drop from race early in memoir

    05:56

  • Trump changes tune on Epstein’s birthday book as Dem lawmakers push for files release

    06:00

  • How the killing of Charlie Kirk could change security protocols for political figures

    08:30

  • Report: Four women who have immunity in the Epstein case may know if there’s a client list

    05:15

  • New NBC News Poll: 21% of Americans FURIOUS with Trump’s second term so far

    10:19

  • Epstein survivor confirms a new client list made by survivors is being put together

    08:32

  • Trump’s disapproval hits 59% on handling of trade and tariffs

    06:25

  • Survivors turn up the heat on Congress to vote for release of Epstein files

    08:52

  • Former Rep. baffled as activist Laura Loomer prevents Dem Senator’s visit to spy agency

    05:22

  • House Speaker claims Trump was an FBI informant in the Epstein case

    10:40

  • Bad news for Trump: Republicans join survivors, Democrats in pursuit of Epstein files

    08:50

  • Survivors of Epstein deliver powerful demand for transparency to Trump administration

    06:29

  • Trump threatens Chicago with mass deportations as Mexican Independence Day celebrations take place

    04:51

  • Pressure mounts on Trump, Speaker Johnson to release Epstein files after survivors news conference

    07:08

  • Exclusive: DOJ says names of two associates Epstein wired money to should stay secret

    02:36

  • Prepare for inflation: Back-to-school prices soared, holiday gifts likely will too

    03:36

  • Trump’s winning streak: Law professor breaks down his Supreme Court shadow docket victories

    07:03

  • Now Playing

    Trump’s economy takes a toll on middle-class Americans as his poll numbers on economics fall

    08:03

  • UP NEXT

    How social media can have an influence in attempted assassinations and mass shootings

    11:38

  • What Congress should ask FBI Director Patel about in next week’s Epstein files deposition

    06:23

  • Fmr. Vice President Harris shares internal debate on asking Biden to drop from race early in memoir

    05:56

  • Trump changes tune on Epstein’s birthday book as Dem lawmakers push for files release

    06:00

Read More

Continue Reading

The Dictatorship

What Trump’s wildly different responses to two assassinations tell us

Published

on

What Trump’s wildly different responses to two assassinations tell us

In his sharply differing reactions to two high-profile assassinations of political figures this year, the president of the United States has effectively encouraged the public to apply a partisan lens to the value of human life.

The two killings in question — a lone wolf assassination of former Minnesota House Speaker Melissa Hortman in June and the shooting of Turning Point USA founder Charlie Kirk at a Utah Valley University speaking event this past week — elicited very different kinds of treatment from the White House. President Donald Trump gave scant attention to Hortman’s killing, while he framed the killing of Kirk as a cataclysmic national tragedy and a political rallying cry for the right.

Republican lives matter more than Democratic lives, Trump is effectively telling his base.

Republican lives matter more than Democratic lives, Trump is effectively telling his base. And in a shocking comment on “Fox & Friends” on Friday, Trump appeared to use Kirk’s assassination to explicitly designate political violence a partisan issue too, by defending violent right-wing extremists as sharing his political goals of bringing down “crime” and left-wing extremists as “the problem.”

In response to the murder of Hortman, Trump offered a brief, impersonal condemnation of her killing on Truth Social, stating that “such horrific violence will not be tolerated.” He didn’t do much else. He did not offer a substantial eulogy for her, or deliver an address on political violence, as he did after Kirk’s death. Unlike former President Joe Biden, Trump did not attend the funeral. The day after Hortman’s killing, when Trump was asked if he had called Minnesota Gov. Tim Walz, he said, “I could be nice and call, but why waste time?” Trump suggested that part of the reason he didn’t want to call Walz was because he thought Walz was to blame for the killing, or at least the events leading up to it. That claim was nonsense. But peddling that narrative did allow Trump to divert attention from the fact that authorities found the suspected shooter had a hit list that named mostly Democratic politicians or figures tied to abortion rights, and that his close childhood friend said he voted for Trump.

In response to Kirk’s killing, Trump responded with tremendous urgency. He immediately issued an order to lower American flags to half-staff at the White House, all public buildings, U.S. embassies and military posts. He announced he would award Kirk the Presidential Medal of Freedom posthumously. He delivered a wrathful four-minute video address from the White House condemning Kirk’s assassination and promising vengeance against the left. As my colleague Anthony Fisher notesduring that address he made “wildly irresponsible assumptions about the then-unknown suspected killer’s motives. He completely ignored right-wing violence (like the kind he incited in Washington on Jan. 6, 2021), and he explicitly threatened to bring down the force of government on his political opponents.”

It was bad enough that Trump showed such divergent responses to the equally indefensible assassinations of Hortman and Kirk — and used the latter to promote the idea of a political crackdown on the left. But his appearance on Fox News on Friday morning involved what I found to be a genuinely jaw-dropping escalation, as he appeared to suggest that violence from the right was more defensible than violence from the left. Fox News host Ainsley Earhardt noted that there are radicals on both the right and the left and expressed concern about people cheering for Kirk’s death before asking Trump, “How do we fix this country?” He replied:

I’ll tell you something that’s going to get me in trouble, but I couldn’t care less. The radicals on the right oftentimes are radical because they don’t want to see crime. They don’t want to see crime. They’re saying, ‘We don’t want these people coming in. We don’t want you burning our shopping centers. We don’t want you shooting our people in the middle of the street.’ The radicals on the left are the problem. And they’re vicious, and they’re horrible, and they’re politically savvy.

What Trump appears to be saying is that left-wing radicals are a problem, while right-wing extremists are, in essence, part of his political project and therefore don’t deserve condemnation — or at least not the kind of condemnation that those on the left do. He is effectively telegraphing the idea that a certain degree of political violence on the right could be acceptable — or at least should be seen as politically sympathetic and well-intentioned. As right-wing extremists are reactivating and rallying around Kirk’s death as a pretext for revenge against the left, Trump’s new statement echoes his “stand back and stand by” order to the Proud Boys in 2020 before they stormed the U.S. Capitol on Jan. 6. It would be reasonable in this context for right-wing extremists to surmise that Trump is again signaling that he could be lax on enforcement or try to offer them some kind of immunity — just as he did by commuting the sentences of Proud Boys and pardoning their leader.

In a democracy, all political violence should be considered entirely unacceptable, no matter the ideology of the person committing the act or on the receiving end of it. Both the deaths of Hortman and Kirk were terrible tragedies and completely unjustifiable. But in his selective mourning and politicization of their deaths, Trump suggested one tragedy — more importantly, one type of tragedy — mattered more.

Zeeshan aleem

Zeeshan Aleem is a writer and editor for BLN Daily. Previously, he worked at Vox, HuffPost and Blue Light News, and he has also been published in, among other places, The New York Times, The Atlantic, The Nation, and The Intercept. You can sign up for his free politics newsletter here.

Read More

Continue Reading

The Dictatorship

The data on vaccine safety is public and clear — but I just spelled it out for Congress anyway

Published

on

The data on vaccine safety is public and clear — but I just spelled it out for Congress anyway

(The following is testimony presented to the U.S. Senate Permanent Subcommittee on Investigations on Sept. 9. It has been edited for style and length.)

The scientific evidence supporting vaccine safety and efficacy represents one of the most extensive and transparent bodies of medical research ever assembled. Vaccines have saved an estimated 154 million lives globally over 50 years, eliminated smallpox from the planet and reduced diseases like polio and measles by over 99% in the United States.

Anyone with internet access can read the same studies I read, examine the same data I examine and verify the same conclusions.

Since April 2025, I have co-led the development of a comprehensive public database cataloging 1,704 randomized controlled trials of vaccines spanning from 1941 to 2025, involving more than 10.5 million participants. Multiple independent U.S. surveillance systems continuously monitor vaccine safety in real time, detecting adverse events as rare as 1 per 1 million doses. Recent large-scale studies, including a Danish cohort following 1.2 million children, consistently demonstrate vaccine safety across diverse populations.

The Centers for Disease Control and Prevention estimates that vaccines given to U.S. children born between 1994 and 2023 will prevent approximately 508 million illnesses, 32 million hospitalizations and 1,129,000 deaths over their lifetimes, saving nearly $2.7 trillion in societal costs. This vast evidence base is publicly accessible, peer-reviewed and continuously updated. If vaccines caused a wave of chronic disease, our safety systems — which can detect one-in-a-million events — would have seen it. They haven’t.

I am also part of the Center for Infectious Disease Research and Policy’s Vaccine Integrity Projectwhere our team is conducting a systematic review and meta-analysis of respiratory virus immunizations from approximately the last two years. This ongoing analysis has examined 590 studies from over 17,000 identified references to date.

As an infectious diseases physician at Stanford University School of Medicine, I have treated many adults with vaccine-preventable diseases throughout my career. These clinical experiences, combined with my research analyzing the extensive evidence base for vaccine safety and efficacy, inform my testimony today.

I should note that I am here in my personal capacity, and the views I share reflect my own professional experience and analysis of the scientific evidence. I have received minimal payments totaling $45.62 over multiple years for food and beverage at work-related events, as documented in the federal Open Payments database. My research time is either self-funded or supported by Stanford University. I testify in my personal capacity as a physician-scientist committed to rigorous evidence and transparent science.

The safety and efficacy data for vaccines is published in peer-reviewed journals, accessible through PubMed, analyzed by independent researchers worldwide, and scrutinized by regulatory agencies whose deliberations are public record. Anyone with internet access can read the same studies I read, examine the same data I examine and verify the same conclusions.

Our international team has built a public database of randomized controlled trials of vaccines. Every entry links directly to its peer-reviewed source publication, allowing anyone to examine the methods, data and results independently. This is how science should work — open, transparent and reproducible.

The transparency of vaccine science extends throughout history. When Edward Jenner published his vaccination findings in 1798, he self-published Variolae Vaccinae for public scrutiny. The 1954 Salk polio vaccine trial involved 1.8 million children in a publicly monitored study, with results announced to the world and data published for examination. This tradition continues today with large-scale epidemiologic studies published in peer-reviewed journals for all to examine.

The United States maintains multiple independent vaccine safety monitoring systems, each operating transparently.

When real risks exist, they are detected, quantified, disclosed and incorporated into guidance. That is how a functioning safety system works.

The Vaccine Adverse Event Reporting System (VAERS) makes every report publicly accessible at vaers.hhs.gov, where anyone can search, download and analyze raw data. The Vaccine Safety Datalink (VSD) covers over 10 million Americans across nine health care organizations, with findings regularly published in peer-reviewed journals and presented at public Advisory Committee meetings. The Post-licensure Rapid Immunization Safety Monitoring (PRISM) system monitors over 190 million people, publishing results openly.

These systems have successfully detected rare adverse events — including intestinal blockage with a rotavirus vaccine in 1999, leading to its withdrawal; rare blood clots with the Johnson & Johnson Covid vaccine (3 per 1 million doses), detected within weeks; and myocarditis signals with mRNA vaccinespromptly investigated and quantified.

When real risks exist, they are detected, quantified, disclosed and incorporated into guidance. That is how a functioning safety system works.

Vaccination has historically united Americans across political lines. George Washington ordered Continental Army variolation against smallpox in 1777, declaring, “I have determined that the troops shall be inoculated.” His orders, preserved in the Library of Congress, reflect understanding that disease threatened his army more than British forces.

Throughout American history, presidents from both parties have championed vaccination as essential public health policy. President Dwight D. Eisenhower signed the Poliomyelitis Vaccination Assistance Act in 1955, stating, “We all hope that the dread disease of poliomyelitis can be eradicated from our society.” President Ronald Reagan proclaimed National Adult Immunization Awareness Week, noting that “vaccination against infectious diseases saves lives and lowers health care costs.” President George H.W. Bush mobilized CDC teams to cities during the 1991 measles resurgence, urging parents: “The vaccines are available. Please, make sure your child is immunized.” Even recently, President Donald Trump acknowledged: “Look, you have vaccines that work — they just pure and simple work. They’re not controversial at all.”

The evidence of vaccine effectiveness is documented in every health department report and mortality database. This data is not hidden — it is published by the CDC and available to anyone.

Before vaccines, measles infected 3-4 million Americans annually, killing approximately 500 children each year. After widespread vaccination led to elimination in 2000, deaths typically numbered zero to two per year. We are currently experiencing our worst outbreak in decades — 1,431 cases through September 2025, with three deaths, overwhelmingly in undervaccinated communities.

Polio paralyzed 16,000 Americans annually in the pre-vaccine era. In 1952 alone, polio caused 57,879 cases and 3,145 deaths, and paralyzed 21,269 Americans. Since 1979there have been zero cases of wild poliovirus in the United States — a 100% reduction.

Haemophilus influenzae type b (Hib) caused 20,000 cases of severe disease in children under 5 each year, killing approximately 1,000 annually. After vaccine introduction in 1987, cases dropped by over 99%. From 2009 to 2018, only 36 total Hib cases occurred in American children under 5 — across that entire decade.

The transformation is striking: diphtheria killed 13,000-15,000 Americans annually in the early 20th century; in 2024, we had one case. Pertussis killed hundreds of infants yearly; today, typically fewer than 10. Vaccines have saved an estimated 154 million lives globally over 50 years, including 146 million children under 5 years old and 101 million infants. For every death averted, 66 years of full health were gained on average, translating to 10.2 billion years of full health gained. Vaccination has accounted for 40% of the observed decline in global infant mortality — 52% in Africa. In 2024, a child under 10 years old is 40% more likely to survive to their next birthday because of historical vaccination programs.

For respiratory virus vaccines, the primary goal and realistic expectation is to prevent severe disease and death, not infection.

During the 2023-24 influenza season, over 200 children died from flu; among vaccine-eligible children with known vaccination status, more than 80% were not fully vaccinated. Covid-19 vaccines, developed with unprecedented transparency through publicly broadcast Food and Drug Administration and CDC meetings, prevented catastrophic loss of life. A rigorous analysis estimated vaccines prevented 2.5 million deaths globally from 2020 to 2024 (with sensitivity estimates ranging from 1.4-4.0 million). Before vaccines, ICUs were overwhelmed. By mid-2021, nearly every fatal case was among the unvaccinated. During the delta surge, unvaccinated adults were 53 times more likely to die than those vaccinated and boosted.

I cared for hundreds of Covid patients and watched far too many die. I lost many unvaccinated patients across the age spectrum — from their 30s to their 90s — who I am certain would have survived had they been vaccinated. One mother in her 40s without underlying conditions declined vaccination and died, leaving her child behind. These statistics represent preventable human tragedies.

When vaccine safety is studied with robust designs — large, linked databases, matched cohorts, self-controlled methods comparing people to themselves over time — the findings are consistent: no broad increase in chronic diseases among vaccinated people.

Every medical intervention exists on a spectrum of effectiveness. Statins reduce heart attack risk by approximately 30%, not 100%. Cancer chemotherapy may help roughly 40% of patients, not all. We use these treatments because benefits outweigh limitations. Influenza vaccines, used since the 1940s, prevent an estimated 40%-60% of influenza illness in good years, perhaps 20% when the match is poor — yet still prevent thousands of deaths annually.

For respiratory virus vaccines, the primary goal and realistic expectation is to prevent severe disease and death, not infection. While vaccines cannot prevent viruses from initially entering the respiratory tract, they help our immune system recognize the pathogen and mount a rapid response that can prevent infection, transmission or severe disease, depending on the variant and vaccine match. But vaccines excel at keeping people out of the hospital, and for that critical goal, they perform remarkably well.

Our surveillance systems’ transparency was demonstrated during Covid-19 vaccine monitoring. When the possibility of an early myocarditis signal emerged, the CDC issued a Health Alert Network notice on May 27, 2021, urging clinicians to report cases to verify whether a true safety signal existed. Once confirmed through enhanced surveillance, the Advisory Committee on Immunization Practices reviewed data publicly on June 23. The FDA added warnings on June 25. The data showed rates peaked at approximately 106 per million second doses in teenage boys in 2021, mostly mild and short-lived. By 2024-25, rates with updated formulations returned to near background levels, as documented in public ACIP presentations.

Our surveillance systems can detect extremely rare adverse events — as rare as 1 event per 1 million doses or even less. These systems identified thrombosis with thrombocytopenia syndrome (blood clots and low platelets) after the J&J vaccine at a few per million doses overall. The sensitivity of these systems would make any widespread vaccine-related chronic disease impossible to miss.

We take vaccine safety extremely seriously. Vaccines are unique medicines given to large numbers of healthy people. Ensuring their safety through rigorous testing and continuous monitoring is critical.

The evidence for vaccine safety and efficacy exists in overwhelming abundance, accessible to anyone willing to examine it.

My current work exemplifies commitment to openness. Our public database is openly accessible, with search strategies available in the spreadsheets for anyone to examine and verify. The Vaccine Integrity Project team discussed our methods at a public webinardemonstrating our commitment to transparency even before publication. Every step of our research process is designed to be reproducible and verifiable.

Beyond clinical trials, thousands of additional studies examine vaccine safety through peer-reviewed research. When concerns arise, they are investigated and results are published, whether confirming or refuting initial hypotheses.

The evidence for vaccine safety and efficacy exists in overwhelming abundance, accessible to anyone willing to examine it. From Washington’s orders to inoculate the Continental Army to today’s real-time safety monitoring systems, American vaccination policy has been built on transparency and evidence.

The data supporting vaccines is not hidden — it is reviewed by the FDA, published in peer-reviewed journals, analyzed worldwide and tracked through public surveillance systems. If vaccines caused widespread chronic disease, our safety monitoring systems would have detected it. They haven’t.

The question before this subcommittee is whether public health policy will continue to be guided by transparent, peer-reviewed evidence. As we face both emerging infectious disease threats and the return of old threats due to declining vaccination coverage — like our current measles outbreak — maintaining public confidence through evidence-based communication remains essential.

The data is public. The evidence is clear. I welcome your questions.

Jake Scott

Dr. Jake Scott is an infectious disease physician and Clinical Associate Professor at Stanford University School of Medicine in the Division of Infectious Diseases and Geographic Medicine.

Read More

Continue Reading

Trending